{"anticipatedPostingDate":"2026-09","denomUnitsSelected":"Participants","description":"MRD negativity rate was the percentage of participants with CR/sCR and with negative MRD per IMWG sequencing criteria.","reportingStatus":"NOT_POSTED","timeFrame":"From date of first dose until confirmed disease progression, death, start of new anticancer therapy, whichever occurred first (up to approximately 37 months)","title":"Minimal Residual Disease (MRD) Negativity Rate Per IMWG Sequencing Criteria","type":"SECONDARY"}